Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prulifloxacin versus cefixime prophylaxis before prostate biopsy
ACTRN12616001344482Phase 4Not yet recruiting
- Sponsor
- University of Thessaly
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of prulifloxacin and cefixime in urinary tract infection (UTI) (2 arms), sponsored by University of Thessaly. Primary endpoint: High fever with lower urinary tract symptoms. Planned start Nov 2016; status: not yet recruiting.
02
Drugs
prulifloxacincefixime
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on ACTRN12616001344482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001344482.